换一批Activity of Platinum-Based Chemotherapy in Patients With Advanced Prostate Cancer With and Without DNA Repair Gene Aberrations.
第一作者：
Sabine,Schmid
第一单位：
Department of Medical Oncology and Haematology, Cantonal Hospital of St Gallen, St Gallen, Switzerland.;Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Canada.
作者：
Sabine,Schmid [1]
;
Aurelius,Omlin [2]
;
Celestia,Higano [3]
;
Christopher,Sweeney [4]
;
Nieves,Martinez Chanza [4]
;
Niven,Mehra [5]
;
Malou C P,Kuppen [6]
;
Himisha,Beltran [7]
;
Vincenza,Conteduca [8]
;
Daniel,Vargas Pivato de Almeida [9]
;
Fernando,Cotait Maluf [10]
;
William K,Oh [11]
;
Che-Kai,Tsao [11]
;
Oliver,Sartor [12]
;
Elisa,Ledet [12]
;
Giuseppe,Di Lorenzo [13]
;
Steven M,Yip [14]
;
Kim N,Chi [14]
;
Diletta,Bianchini [15]
;
Ugo,De Giorgi [8]
;
Aaron R,Hansen [16]
;
Tomasz M,Beer [17]
;
Pernelle,Lavaud [18]
;
Rafael,Morales-Barrera [19]
;
Marcello,Tucci [20]
;
Elena,Castro [21]
;
Kostas,Karalis [22]
;
Andries M,Bergman [23]
;
Mo Linh,Le [24]
;
Ursina,Zürrer-Härdi [25]
;
Carmel,Pezaro [26]
;
Hiroyoshi,Suzuki [27]
;
Andrea,Zivi [28]
;
Dirk,Klingbiel [29]
;
Sämi,Schär [29]
;
Silke,Gillessen [30]
作者单位：
Department of Medical Oncology and Haematology, Cantonal Hospital of St Gallen, St Gallen, Switzerland.;Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Canada.
[1]
Department of Medical Oncology and Haematology, Cantonal Hospital of St Gallen, St Gallen, Switzerland.
[2]
Seattle Cancer Care Alliance, University of Washington, Seattle.
[3]
Department of Medical Oncology, Dana Farber Cancer Institute, Boston, Massachusetts.
[4]
Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands.
[5]
Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands.;Institute for Medical Technology Assessment, Erasmus School of Health Policy and Management, Erasmus University, Rotterdam, the Netherlands.
[6]
Department of Medical Oncology, Dana Farber Cancer Institute, Boston, Massachusetts.;Department of Medical Oncology, Weill Cornell Medicine, New York, New York.
[7]
Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori IRCCS, Meldola, Italy.
[8]
Department of Medical Oncology Beneficencia Portuguesa de São Paulo, São Paulo, Brazil.;Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, New York.
[9]
Department of Medical Oncology, Hospital Israelita Albert Einstein, Beneficencia Portuguesa de São Paulo, São Paulo, Brazil.;Oncoclinicas Oncology Group, Brasilia, Brazil.
[10]
Division of Hematology and Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine, Mount Sinai Hospital, New York, New York.
[11]
Tulane Cancer Center, Tulane Medical School, New Orleans, Louisiana.
[12]
Medical Oncology, Department of Medicine and Health Sciences Vincenzo Tiberio, University of Molise, Campobasso, Italy.
[13]
British Columbia Cancer, Vancouver, Canada.
[14]
Division of Clinical Studies, Prostate Cancer Targeted Therapies Group, Institute of Cancer Research, Royal Marsden NHS Foundation Trust, Sutton, United Kingdom.;Maidstone Hospital, Kent, United Kingdom.
[15]
Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Canada.
[16]
Oregon Health and Science Knight Cancer Institute, Oregon Health and Science University, Portland.
[17]
Department of Cancer Medicine, Gustave Roussy, Cancer Campus, Grand Paris, Université Paris-Sud, Université Paris-Saclay, Villejuif, France.
[18]
Department of Medical Oncology, Vall d'Hebron University Hospital, Barcelona, Spain.
[19]
Division of Medical Oncology, San Luigi Gonzaga Hospital, Department of Oncology, University of Turin, Orbassano, Turin, Italy.
[20]
Prostate Cancer Clinical Research Unit, Spanish National Cancer Research Centre, Madrid, Spain.
[21]
Department of Genitourinary Medical Oncology, Athens Medical Center, Athens, Greece.
[22]
Division of Internal Medicine and Oncogenomics, Netherlands Cancer Institute, Amsterdam, the Netherlands.
[23]
Guy's and St Thomas' Hospital, London, United Kingdom.
[24]
Department of Medical Oncology, Cantonal Hospital Winterthur, Winterthur, Switzerland.
[25]
Department of Oncology, Eastern Health, Box Hill, Victoria, Australia.
[26]
Department of Urology, Toho University Sakura Medical Center, Chiba, Japan.
[27]
Department of Medical Oncology, Azienda Ospedaliera Universitaria Integrata di Verona, Verona, Italy.;Section of Cancer, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London, United Kingdom.
[28]
Coordinating Center, Swiss Group for Clinical Cancer Research, Bern, Switzerland.
[29]
Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.;Faculty of Biomedical Sciences, Università della Svizzera Italiana, Lugano, Switzerland.
[30]
主题词
成年人(Adult);老年人(Aged);老年人, 80以上(Aged, 80 and over);抗肿瘤药(Antineoplastic Agents);DNA修复缺陷相关疾病(DNA Repair-Deficiency Disorders);药物疗法(Drug Therapy);人类(Humans);男(雄)性(Male);中年人(Middle Aged);紫杉酚(Paclitaxel);铂化合物(Platinum Compounds);前列腺肿瘤(Prostatic Neoplasms);回顾性研究(Retrospective Studies)
DOI
10.1001/jamanetworkopen.2020.21692
PMID
33112397
发布时间
2021-06-27
- 浏览0
JAMA network open
JAMA network open
2020年3卷10期
e2021692页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
